These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 12596519)

  • 41. Adenosine A2A analogue reduces long-term neurologic injury after blunt spinal trauma.
    Reece TB; Davis JD; Okonkwo DO; Maxey TS; Ellman PI; Li X; Linden J; Tribble CG; Kron IL; Kern JA
    J Surg Res; 2004 Sep; 121(1):130-4. PubMed ID: 15313386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spinal cord injury in neonates alters respiratory motor output via supraspinal mechanisms.
    Zimmer MB; Goshgarian HG
    Exp Neurol; 2007 Jul; 206(1):137-45. PubMed ID: 17559837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Therapeutic efficacy of N6-cyclopentyladenosine against acute dichlorvos poisoning].
    Zhu QH; Huang JX; Lin Z
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2005 Apr; 23(2):94-6. PubMed ID: 16105447
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adenosine A1 and A2 receptor agonists reduce endotoxin-induced cellular energy depletion and oedema formation in the lung.
    Heller AR; Rothermel J; Weigand MA; Plaschke K; Schmeck J; Wendel M; Bardenheuer HJ; Koch T
    Eur J Anaesthesiol; 2007 Mar; 24(3):258-66. PubMed ID: 17094869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A neuroprotective role of glial cell line-derived neurotrophic factor following moderate spinal cord contusion injury.
    Iannotti C; Ping Zhang Y; Shields CB; Han Y; Burke DA; Xu XM
    Exp Neurol; 2004 Oct; 189(2):317-32. PubMed ID: 15380482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Involvement of adenosine A1 and A2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of cocaine and methamphetamine in rats.
    Justinova Z; Ferre S; Segal PN; Antoniou K; Solinas M; Pappas LA; Highkin JL; Hockemeyer J; Munzar P; Goldberg SR
    J Pharmacol Exp Ther; 2003 Dec; 307(3):977-86. PubMed ID: 14557381
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 3'-Aminoadenosine-5'-uronamides: discovery of the first highly selective agonist at the human adenosine A3 receptor.
    DeNinno MP; Masamune H; Chenard LK; DiRico KJ; Eller C; Etienne JB; Tickner JE; Kennedy SP; Knight DR; Kong J; Oleynek JJ; Tracey WR; Hill RJ
    J Med Chem; 2003 Jan; 46(3):353-5. PubMed ID: 12540233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of cyclopentyladenosine on lipid peroxidation during focal cerebral ischemia.
    Sufianova GZ; Sufianov AA; Shapkin AG
    Bull Exp Biol Med; 2014 Jun; 157(2):228-30. PubMed ID: 24952491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Anticonvulsant and neuroprotective effects of cyclopentyladenosine on the model of convulsive status in rats].
    Sufianova GZ; Sufianov AA; Shapkin AG
    Eksp Klin Farmakol; 2013; 76(11):13-8. PubMed ID: 24555227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adenosine and neurotrauma: therapeutic perspectives.
    Phillis JW; Goshgarian HG
    Neurol Res; 2001; 23(2-3):183-9. PubMed ID: 11320597
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clearance of cyclopentyladenosine and cyclohexyladenosine in rats following a single subcutaneous dose.
    Tuovinen K; Tarhanen J
    Pharmacol Res; 2004 Sep; 50(3):329-34. PubMed ID: 15225677
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adenosine: does it have a neuroprotective role after all?
    de Mendonça A; Sebastião AM; Ribeiro JA
    Brain Res Brain Res Rev; 2000 Sep; 33(2-3):258-74. PubMed ID: 11011069
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A reassessment of LPS/indomethacin/pregnenolone combination therapy after spinal cord injury in rats.
    Guth L
    Exp Neurol; 2012 Feb; 233(2):686. PubMed ID: 22134153
    [No Abstract]   [Full Text] [Related]  

  • 54. Adenosine: a prototherapeutic concept in neurodegeneration.
    von Lubitz DK; Carter MF; Beenhakker M; Lin RC; Jacobson KA
    Ann N Y Acad Sci; 1995 Sep; 765():163-78; discussion 196-7. PubMed ID: 7486604
    [No Abstract]   [Full Text] [Related]  

  • 55. A spinal cord injury prevention program.
    Pierson P; Pierson E; Gelber B
    Nebr Med J; 1986 May; 71(5):133. PubMed ID: 3713908
    [No Abstract]   [Full Text] [Related]  

  • 56. Alternate explanation of the additive protective effects of regional infusion of hypothermic saline and adenosine solutions.
    Miyamoto TA; Miyamoto KJ
    J Thorac Cardiovasc Surg; 2000 Mar; 119(3):631-2. PubMed ID: 10694630
    [No Abstract]   [Full Text] [Related]  

  • 57. A word of caution in extrapolating the riluzole spinal cord injury protective effects obtained in a rabbit model under ketamine anesthesia.
    Lang-Lazdunski L; Heurteaux C; Lazdunski M
    J Thorac Cardiovasc Surg; 1999 Dec; 118(6):1157. PubMed ID: 10596004
    [No Abstract]   [Full Text] [Related]  

  • 58. Erratum: Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury.
    Gaudin A; Yemisci M; Eroglu H; Lepetre-Mouelhi S; Turkoglu OF; Dönmez-Demir B; Caban S; Sargon MF; Garcia-Argote S; Pieters G; Loreau O; Rousseau B; Tagit O; Hildebrandt N; Dantec YL; Mougin J; Valetti S; Chacun H; Nicolas V; Desmaële D; Andrieux K; Capan Y; Dalkara T; Couvreur P
    Nat Nanotechnol; 2015 Jan; 10(1):99. PubMed ID: 25559969
    [No Abstract]   [Full Text] [Related]  

  • 59. [Protective effect of adenosine receptor agonists in a model of spinal cord injury in rats].
    Sufianova GZ; Usov LA; Sufianov AA; Perelomov IuP; Raevskaia LIu; Shapkin AG
    Eksp Klin Farmakol; 2002; 65(5):58-61. PubMed ID: 12596519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Protective effect of A-agonists in a minimum invasive model of spinal cord ischemia in rats].
    Sufianova GZ; Usov LA; Sufianov AA; Shapkin AG; Raevskaia LIu; Golubev SS
    Eksp Klin Farmakol; 2003; 66(1):23-6. PubMed ID: 12683076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.